Delivery Order SPE2DB22D2206-SPE2DB24FJD37

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTREXUP 22.5 MG/0.4 ML AUTOINJ 0.4ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,427.22 and an ultimate completion date of August 21, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.94 firm fixed-price delivery order is for the pharmaceutical product OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,639.72 firm fixed-price delivery order is for the OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML medical product. The contract has an ultimate completion date of July 17, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML. The contract has a ceiling value of $5,833.20 and is a firm fixed price delivery order running through March 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,079.54, is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date for this award is March 17, 2025. This contract award is not designated as a set-aside....
This federal contract award, valued at $11,559.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award, which is a delivery order, is for the provision of a variety of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award, valued at $4,545.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of a variety of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen has a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $12,990.43, was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, which runs through April 30, 2024, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award, valued at $1,251.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,039,567.41. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to supply a wide range of pharmaceutical products and medical supplies. This includes specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJD37
    Delivery Order

This federal contract award, valued at $1,841.68, was issued by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a medication, with a completion date of July 12, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This award is not a set-aside contract.

Generated 10/10/24, 9:15 AM